Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats

Neuroscience Letters

Volumn 517, Issue 1, 2012, Pages 60-63

  Hu, Ji Hua ^a   Zheng, Xiao Yan ^a   Yang, Jian Ping ^a   Wang, Li Na ^a   Ji, Fu Hai ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cancer induced bone pain; CCR2; Chemokine; MCP 1; Rat

Indexed keywords

CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY;

ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CANCER; BONE PAIN; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; TIBIA;

ANIMALS; BONE NEOPLASMS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPERALGESIA; INJECTIONS, SPINAL; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR2; SPINAL CORD;

EID: 84860594175     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.04.026     Document Type: Article

References (27)

1. Abbadie C., Bhangoo S., De Koninck Y., Malcangio M., Melik-Parsadaniantz S., White F.A. Chemokines and pain mechanisms. Brain Res Rev 2009, 60:125-134.
2. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:7947-7952.
3. Boddeke E.W., Meigel I., Frentzel S., Gourmala N.G., Harrison J.K., Buttini M., Spleiss O., Gebicke-Harter P. Cultured rat microglia express functional beta-chemokine receptors. Journal of Neuroimmunology 1999, 98:176-184.
4. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. Journal of Neuroscience Methods 1994, 53:55-63.
5. Dansereau M.A., Gosselin R.D., Pohl M., Pommier B., Mechighel P., Mauborgne A., Rostene W., Kitabgi P., Beaudet N., Sarret P., Melik-Parsadaniantz S. Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. Journal of Neurochemistry 2008, 106:757-769.
6. Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., Ji R.R. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. Journal of Neuroscience 2009, 29:4096-4108.
7. Gosselin R.D., Varela C., Banisadr G., Mechighel P., Rostene W., Kitabgi P., Melik-Parsadaniantz S. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. Journal of Neurochemistry 2005, 95:1023-1034.
8. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 2000, 98:585-598.
9. Jeon S.M., Sung J.K., Cho H.J. Expression of monocyte chemoattractant protein-1 and its induction by tumor necrosis factor receptor 1 in sensory neurons in the ventral rhizotomy model of neuropathic pain. Neuroscience 2011, 190:354-366.
10. Jung H., Bhangoo S., Banisadr G., Freitag C., Ren D., White F.A., Miller R.J. Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. Journal of Neuroscience 2009, 29:8051-8062.
11. Knerlich-Lukoschus F., Juraschek M., Blomer U., Lucius R., Mehdorn H.M., Held-Feindt J. Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat. Journal of Neurotrauma 2008, 25:427-448.
12. Lan L.S., Ping Y.J., Na W.L., Miao J., Cheng Q.Q., Ni M.Z., Lei L., Fang L.C., Guang R.C., Jin Z., Wei L. Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol Pain 2010, 6:2.
13. Liu S., Yang J., Wang L., Jiang M., Qiu Q., Ma Z., Liu L., Li C., Ren C., Zhou J., Li W. Tibia tumor-induced cancer pain involves spinal p38 mitogen-activated protein kinase activation via TLR4-dependent mechanisms. Brain Research 2010, 1346:213-223.
14. Luger N.M., Mach D.B., Sevcik M.A., Mantyh P.W. Bone cancer pain: from model to mechanism to therapy. Journal of Pain and Symptom Management 2005, 29:S32-S46.
15. Mantyh P.W. Cancer pain and its impact on diagnosis, survival and quality of life. Nature Reviews Neuroscience 2006, 7:797-809.
16. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nature Reviews Neuroscience 2009, 10:23-36.
17. Peters C.M., Eisenach J.C. Contribution of the chemokine (C-C motif) ligand 2 (CCL2) to mechanical hypersensitivity after surgical incision in rats. Anesthesiology 2010, 112:1250-1258.
18. Pfaffl M.W., Horgan G.W., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 2002, 30:e36.
19. Sandhir R., Gregory E., He Y.Y., Berman N.E. Upregulation of inflammatory mediators in a model of chronic pain after spinal cord injury. Neurochemical Research 2011, 36:856-862.
20. Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D., Thompson S.W., Marchand F., McMahon S.B. CCL2 is a key mediator of microglia activation in neuropathic pain states. European Journal of Pain 2009, 13:263-272.
21. Van Steenwinckel J., Reaux-Le Goazigo A., Pommier B., Mauborgne A., Dansereau M.A., Kitabgi P., Sarret P., Pohl M., Melik Parsadaniantz S. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. Journal of Neuroscience 2011, 31:5865-5875.
22. Vit J.P., Ohara P.T., Tien D.A., Fike J.R., Eikmeier L., Beitz A., Wilcox G.L., Jasmin L. The analgesic effect of low dose focal irradiation in a mouse model of bone cancer is associated with spinal changes in neuro-mediators of nociception. Pain 2006, 120:188-201.
23. Wang L.N., Yang J.P., Zhan Y., Ji F.H., Wang X.Y., Zuo J.L., Xu Q.N. Minocycline-induced reduction of brain-derived neurotrophic factor expression in relation to cancer-induced bone pain in rats 2011, J Neurosci Res.
24. Wang L.N., Yao M., Yang J.P., Peng J., Peng Y., Li C.F., Zhang Y.B., Ji F.H., Cheng H., Xu Q.N., Wang X.Y., Zuo J.L. Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord. Mol Pain 2011, 7:48.
25. White F.A., Jung H., Miller R.J. Chemokines and the pathophysiology of neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:20151-20158.
26. Zhang J., De Koninck Y. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. Journal of Neurochemistry 2006, 97:772-783.
27. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. Journal of Neuroscience 2007, 27:12396-12406.